HIV expenditure on prevention and treatment in Guinea

Guinea: HIV expenditure on prevention and treatment was 27.77 million constant 2019 US$ in 2024. ◆ Volatile

Latest (2024)
27.77 million constant 2019 US$
Change on year
up 31.7%
World rank
43rd
of 144 countries
All-time high
34.48 million constant 2019 US$
in 2020
All-time low
0 constant 2019 US$
in 2018
Years of data
16
2007–2024

HIV expenditure on prevention and treatment in Guinea, 2007–2024

010.0M20.0M30.0M2007201520242007: 7.4M constant 2019 US$2008: 13.2M constant 2019 US$2009: 13.5M constant 2019 US$2010: 11.9M constant 2019 US$2011: 15.0M constant 2019 US$2012: 12.1M constant 2019 US$2013: 14.4M constant 2019 US$2014: 15.8M constant 2019 US$2016: 20.9M constant 2019 US$2017: 8.9M constant 2019 US$2018: 0 constant 2019 US$2019: 27.3M constant 2019 US$2020: 34.5M constant 2019 US$2021: 16.6M constant 2019 US$2022: 21.1M constant 2019 US$2024: 27.8M constant 2019 US$

Source: Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data. Measured in constant 2019 US$.

Analysis

The most recent figure for hiv expenditure on prevention and treatment in Guinea is 27.77 million constant 2019 US$, measured in 2024.

Compared with earlier readings it is up 31.7% on the previous year and up 76.2% over ten years.

Over the whole period, hiv expenditure on prevention and treatment in Guinea peaked at 34.48 million constant 2019 US$ in 2020 and was at its lowest, 0 constant 2019 US$, in 2018.

Guinea ranks 43rd of 144 countries on this measure, in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Averages by decade

DecadeAverage LowestHighest Years
2000s 11.39 million constant 2019 US$ 7.42 million constant 2019 US$ 13.51 million constant 2019 US$ 3
2010s 14.03 million constant 2019 US$ 0 constant 2019 US$ 27.26 million constant 2019 US$ 9
2020s 24.97 million constant 2019 US$ 16.56 million constant 2019 US$ 34.48 million constant 2019 US$ 4

Countries ranked near Guinea

  1. 40 Kuwait 32.38 million constant 2019 US$ compare
  2. 41 Algeria 31.90 million constant 2019 US$ compare
  3. 42 Cambodia 31.57 million constant 2019 US$ compare
  4. 44 Central African Republic 27.11 million constant 2019 US$ compare
  5. 45 Chad 25.70 million constant 2019 US$ compare
  6. 46 Egypt 25.51 million constant 2019 US$ compare

See the full ranking of 144 places →

More health data for Guinea

All data for Guinea →

Frequently asked questions

What is hiv expenditure on prevention and treatment in Guinea?
Hiv expenditure on prevention and treatment in Guinea was 27.77 million constant 2019 US$ in 2024, according to Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data.
What is the highest hiv expenditure on prevention and treatment recorded in Guinea?
The highest recorded value was 34.48 million constant 2019 US$ in 2020.
What is the lowest hiv expenditure on prevention and treatment recorded in Guinea?
The lowest recorded value was 0 constant 2019 US$ in 2018.
How does Guinea rank for hiv expenditure on prevention and treatment?
Guinea ranks 43rd out of 144 countries with data for 2024.
Is hiv expenditure on prevention and treatment rising or falling in Guinea?
Over the last ten years it is up 76.2%. The long-run trend across the full record is volatile.
Where does this Guinea data come from?
The figures come from Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as part of HIV expenditure on prevention and treatment. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 16 observations, free to reuse under CC BY 4.0 (Our World in Data).

About this data

Indicator
HIV expenditure on prevention and treatment
Unit
constant 2019 US$
Source
Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
144 places, 1,552 data points, 2002–2024
Last refreshed

Total in-country spending on HIV programs and services.